Mercado Global de Síndrome de Morvan – Tendências do setor e previsão para 2028

Análise de mercado e insights: mercado global da síndrome de Morvan

Espera-se que o mercado da síndrome morvan ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado está a crescer a um CAGR de 5,60% no período de previsão de pesquisa acima mencionado. Pesquisas e estudos em curso relacionados com o novo tratamento podem aumentar o crescimento do mercado da síndrome de Morvan.  

Por exemplo,

• O estudo foi publicado na revista “Asian Journal of Transfusion Science” informando que foi utilizado um novo tratamento para a síndrome de Morvan, que é a troca terapêutica plasmática (TPE). Este tratamento foi utilizado no doente quando a terapêutica medicamentosa não foi eficaz e após o quinto TPE o doente conseguiu realizar atividades como caminhar com apoio, a disfunção autonómica e as alterações comportamentais também estavam diminuídas.

A síndrome de Morvan é caracterizada por uma perturbação neurológica rara e potencialmente fatal . Esta doença é também categorizada por disautonomia, neuromiotonia e encefalopatia, juntamente com insónia grave . Alguns dos relatórios confirmaram que a doença apresenta alguns sinais de hiperatividade central, periférica e autonómica, juntamente com manifestações sistémicas, como perda de peso ou febre. A causa da doença pode ser o envenenamento por metais pesados, como o manganês ou o mercúrio. A doença afeta sobretudo a população masculina. O prognóstico da doença é muito mau quando relacionada com o timoma.

O aumento da sensibilização para a saúde e os investimentos em I&D nos setores farmacêutico e das ciências da vida são os fatores para o crescimento do mercado da síndrome morvan. Além disso, a crescente consciencialização sobre as doenças autoimunes entre os consumidores pode aumentar o crescimento do mercado da síndrome morvan. A síndrome de Morvan é uma doença rara e apenas foram relatados poucos doentes de acordo com a literatura e a falta de compreensão sobre a etiologia básica da doença são alguns dos fatores que podem dificultar o crescimento do mercado da síndrome de Morvan.  

This morvan syndrome market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the morvan syndrome market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Morvan Syndrome Market Scope and Market Size

The morvan syndrome market is segmented on the basis of diagnosis, treatment, end-user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of diagnosis, the morvan syndrome market is segmented into cerebrospinal fluid (CSF) analysis, brain MRI, electroencephalogram, positron emission tomography, electromyography and antibodies detection. Antibodies detection is further segmented to VGKC-complex antibodies.
• On the basis of treatment, the morvan syndrome market is segmented into gold therapy, antiepileptic agents and procedures. Antiepileptic agents are further segmented to carbamazepine, valproate, phenobarbital and phenytoin. Procedures are further segmented to thymectomy.
• On the basis of end-user, the morvan syndrome market is segmented to research institutes, hospitals and others.
• On the basis of distribution channel, the morvan syndrome market is segmented into hospital pharmacy and others.

Global Morvan Syndrome Market Country Level Analysis

Global morvan syndrome market is analysed and market size information is provided by country, diagnosis, treatment, end-user and distribution channel as referenced above.

The countries covered in the morvan syndrome market report are the U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

On geographical estimation, North America accounts the largest market share because of increase in healthcare expenditure. In 2019, the healthcare expenditure has increased 4.6% that is USD 3.80 trillion or USD 11,582 per person. Europe holds the second position in the market share due to rising incidence of chronic diseases such as autoimmune disease and government support for the research and development.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The morvan syndrome market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to morvan syndrome market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the morvan syndrome market in the growth period.

Competitive Landscape and Global Morvan Syndrome Market Share Analysis

The morvan syndrome market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to morvan syndrome market.

The major players covered in the global morvan syndrome market report are Pfizer Inc, Eli Lilly and Company, Novartis AG, F. Hoffmann-La Roche Ltd, Eisai Co., Ltd, Allergan, Teva Pharmaceutical Industries Ltd, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Endo International plc, Sun Pharmaceutical Industries Ltd, Mylan N.V., Lupin, Cipla Inc, Aurobindo Pharma, Torrent Pharmaceuticals Ltd, Sanofi, Merck & Co., Inc, Apotex Inc, Mayne Pharma Group Limited among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-60080